SWOG clinical trial number
SWOG-8020
Adriamycin + VP-16 vs Adriamycin Alone in Advanced Adenocarcinoma of the Breast
Closed
Phase
Published
Abbreviated Title
Adriamycin + VP-16 vs Adriamycin Alone in Advanced Adenocarcinoma of the Breast
Activated
09/26/1980
Closed
12/23/1982
Publication Information Expand/Collapse
1988
VP-16 + Adriamycin vs. adriamycin alone in advanced adenocarcinomaof the breast, phase II, A randomized trial: A Southwest Oncology Groupstudy.
1984
Adriamycin + VP-16 vs Adriamycin alone in advanced adenocarcinoma of the breast, Phase II: A Southwest Oncology Group study